[
  {
    "ts": null,
    "headline": "TriSalus Life Sciences, Inc. (TLSI) Reports Q2 Loss, Tops Revenue Estimates",
    "summary": "TriSalus Life Sciences, Inc. (TLSI) delivered earnings and revenue surprises of -22.73% and +5.52%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=ed0eb4c5e111e919d58416b54e28bbf9aee2e8f78f21f7b9c40fde4261b96c74",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755033002,
      "headline": "TriSalus Life Sciences, Inc. (TLSI) Reports Q2 Loss, Tops Revenue Estimates",
      "id": 136328445,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "TriSalus Life Sciences, Inc. (TLSI) delivered earnings and revenue surprises of -22.73% and +5.52%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=ed0eb4c5e111e919d58416b54e28bbf9aee2e8f78f21f7b9c40fde4261b96c74"
    }
  },
  {
    "ts": null,
    "headline": "[Latest] US Surgical Instrument Tracking Market Size/Share Worth USD 226.61 Million by 2034 at a 11.78% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)",
    "summary": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of US Surgical Instrument Tracking Market size & share revenue was valued at approximately USD 74.48 Million in 2024 and is expected to reach USD 83.25 Million in 2025 and is expected to reach around USD 226.61 Million by 2034, at a CAGR of 11.78% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Vizinex (HID Globa",
    "url": "https://finnhub.io/api/news?id=eb5cac009918657375c40123cf6bea4ab02f332230d1e3ef99ffa5aed9f6f7a0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755016200,
      "headline": "[Latest] US Surgical Instrument Tracking Market Size/Share Worth USD 226.61 Million by 2034 at a 11.78% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)",
      "id": 136320729,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of US Surgical Instrument Tracking Market size & share revenue was valued at approximately USD 74.48 Million in 2024 and is expected to reach USD 83.25 Million in 2025 and is expected to reach around USD 226.61 Million by 2034, at a CAGR of 11.78% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Vizinex (HID Globa",
      "url": "https://finnhub.io/api/news?id=eb5cac009918657375c40123cf6bea4ab02f332230d1e3ef99ffa5aed9f6f7a0"
    }
  },
  {
    "ts": null,
    "headline": "ISRG's Post-Earnings Slide: Margin Worries Overshadow Growth Story",
    "summary": "Intuitive Surgical's Q2 revenues and procedure gains look good, but tariffs, cost inflation, and margin pressure spur a post-earnings selloff.",
    "url": "https://finnhub.io/api/news?id=442ef3ca875d1f1990dd60d091392176d881425a55d66b2414abd7d887b9ce74",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755001080,
      "headline": "ISRG's Post-Earnings Slide: Margin Worries Overshadow Growth Story",
      "id": 136320675,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Intuitive Surgical's Q2 revenues and procedure gains look good, but tariffs, cost inflation, and margin pressure spur a post-earnings selloff.",
      "url": "https://finnhub.io/api/news?id=442ef3ca875d1f1990dd60d091392176d881425a55d66b2414abd7d887b9ce74"
    }
  },
  {
    "ts": null,
    "headline": "J&J's MedTech Unit Sales Improve in Q2: Will the Upside Continue?",
    "summary": "Johnson & Johnson's Q2 MedTech sales beat estimates, fueled by cardiovascular gains, surgical vision growth and new product momentum.",
    "url": "https://finnhub.io/api/news?id=32ba43e416a62973a55c0e38baf415158e7527a24a19773743c353f9c87bc87c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755000840,
      "headline": "J&J's MedTech Unit Sales Improve in Q2: Will the Upside Continue?",
      "id": 136320474,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Johnson & Johnson's Q2 MedTech sales beat estimates, fueled by cardiovascular gains, surgical vision growth and new product momentum.",
      "url": "https://finnhub.io/api/news?id=32ba43e416a62973a55c0e38baf415158e7527a24a19773743c353f9c87bc87c"
    }
  },
  {
    "ts": null,
    "headline": "Orchestra BioMed Reports Second Quarter 2025 Financial Results and Highlights Recent Business Updates",
    "summary": "Secured over $111 million in proceeds and committed capital following completion of strategic transactions and concurrent public and private equity offerings, led by over $71 million in committed capital from Medtronic and LigandAchieved multiple FDA regulatory milestones: Breakthrough Device Designation for AVIM therapy; approval for expanded BACKBEAT study enrollment criteria, and IDE approval for a U.S. pivotal Virtue SAB trial versus commercially available paclitaxel-coated balloon NEW HOPE,",
    "url": "https://finnhub.io/api/news?id=a643fe613c40cf99cda798bae8216f4780f41ea7a994eddf0579d6a676b4c0ba",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755000840,
      "headline": "Orchestra BioMed Reports Second Quarter 2025 Financial Results and Highlights Recent Business Updates",
      "id": 136316199,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Secured over $111 million in proceeds and committed capital following completion of strategic transactions and concurrent public and private equity offerings, led by over $71 million in committed capital from Medtronic and LigandAchieved multiple FDA regulatory milestones: Breakthrough Device Designation for AVIM therapy; approval for expanded BACKBEAT study enrollment criteria, and IDE approval for a U.S. pivotal Virtue SAB trial versus commercially available paclitaxel-coated balloon NEW HOPE,",
      "url": "https://finnhub.io/api/news?id=a643fe613c40cf99cda798bae8216f4780f41ea7a994eddf0579d6a676b4c0ba"
    }
  },
  {
    "ts": null,
    "headline": "The Next Generation of Dividend Kings: 3 Stocks to Watch",
    "summary": "These top dividend stocks are steadily marching toward the throne room.",
    "url": "https://finnhub.io/api/news?id=44ae89180eebaef6ee602dd1d77b32992088993203f941889312ab05f9c4b0c6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754989980,
      "headline": "The Next Generation of Dividend Kings: 3 Stocks to Watch",
      "id": 136315983,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "These top dividend stocks are steadily marching toward the throne room.",
      "url": "https://finnhub.io/api/news?id=44ae89180eebaef6ee602dd1d77b32992088993203f941889312ab05f9c4b0c6"
    }
  },
  {
    "ts": null,
    "headline": "US Durable Medical Equipment Market Forecast and Competitive Landscape Report 2025-2033 | Invacare, NOVA, Inogen, Thermo Fisher Scientific, Abbott, Medtronic, Baxter, B. Braun, Boston Scientific, BD",
    "summary": "The United States Durable Medical Equipment Market is projected to grow at a CAGR of 5.03% from 2025 to 2033, reaching $97.10 billion by 2033, driven by rising chronic diseases, an aging population, and increased home healthcare demand. Key segments include personal mobility devices and monitoring and therapeutic equipment, with top players like Invacare, Abbott, and Medtronic leading innovations. California and New York are vibrant markets due to their demographics and healthcare infrastructure",
    "url": "https://finnhub.io/api/news?id=1140dfc5dd7cec2d734c3a79338c0bdded44a93ccec66bce7f41a4885c74bde3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754988120,
      "headline": "US Durable Medical Equipment Market Forecast and Competitive Landscape Report 2025-2033 | Invacare, NOVA, Inogen, Thermo Fisher Scientific, Abbott, Medtronic, Baxter, B. Braun, Boston Scientific, BD",
      "id": 136316075,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "The United States Durable Medical Equipment Market is projected to grow at a CAGR of 5.03% from 2025 to 2033, reaching $97.10 billion by 2033, driven by rising chronic diseases, an aging population, and increased home healthcare demand. Key segments include personal mobility devices and monitoring and therapeutic equipment, with top players like Invacare, Abbott, and Medtronic leading innovations. California and New York are vibrant markets due to their demographics and healthcare infrastructure",
      "url": "https://finnhub.io/api/news?id=1140dfc5dd7cec2d734c3a79338c0bdded44a93ccec66bce7f41a4885c74bde3"
    }
  }
]